Strumento inattivo

Azioni WuXi PharmaTech (Cayman) Inc. (ADR)

Azioni

Prezzo di chiusura Nyse Altri mercati azionari
- ^USD	-

WuXi PharmaTech Cayman : LabNetwork Forges eCommerce Alliances with Leading Chemical Providers	27/04/16
WuXi PharmaTech Cayman : AppTec Congratulates MSD on Receiving FDA Approval of Zepatier	05/02/16
WuXi PharmaTech Cayman : AppTec Congratulates Chia Tai Tianqing Pharmaceutical Group and Janssen for Licensing Agreement	12/01/16
WuXi PharmaTech Cayman : AppTec Plans $120 Million Investment in New Integrated Biologics Solution Center to Expedite Biologics Development from Ideas to Clinic	12/01/16
WuXi PharmaTech Cayman : and AstraZeneca Form Strategic Alliance to Expedite Development of AstraZeneca's Innovative Biologics Portfolio in China	16/12/15

Dirigenti	Titolo	Età	Da
Zhao Hui Zhang FOU	Founder	54	01/01/00
Xiao Zhong Liu FOU	Founder	60	01/01/00
Ge Li CEO	Chief Executive Officer	56	01/01/00

Amministratori	Titolo	Età	Da
Ge Li CEO	Chief Executive Officer	56	01/01/00
Zhao Hui Zhang FOU	Founder	54	01/01/00
Xiao Zhong Liu FOU	Founder	60	01/01/00

Settore

	Variaz. 1 gen.	Capi.
MODERNA, INC.	+41,79%	50,93 Mrd
IQVIA HOLDINGS INC.	-0,56%	42,12 Mrd
LONZA GROUP AG	+49,62%	42,05 Mrd
CELLTRION, INC.	-7,20%	29,18 Mrd
ICON PUBLIC LIMITED COMPANY	+12,59%	26,02 Mrd
ALNYLAM PHARMACEUTICALS, INC.	-21,51%	18,9 Mrd
BIO-TECHNE CORPORATION	+6,92%	13,21 Mrd
UNITED THERAPEUTICS CORPORATION	+24,91%	12,17 Mrd
MEDPACE HOLDINGS, INC.	+29,60%	12,16 Mrd